(Q43146631)

14 November 2017

title

Randomized, controlled, double-blind trial of taranabant for smoking cessation (English)

1 reference

14 November 2017

Mary F Morrison

1

1 reference

14 November 2017

Paulette Ceesay

2

1 reference

14 November 2017

Ira Gantz

3

1 reference

14 November 2017

Keith D Kaufman

4

1 reference

14 November 2017

Christopher R Lines

5

1 reference

14 November 2017

publication date

27 February 2010

1 reference

14 November 2017

number of pages

9

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

14 November 2017

volume

209

1 reference

14 November 2017

issue

3

1 reference

14 November 2017

page(s)

245-253

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-010-1790-2

14 November 2017

exact match

0 references

cites work

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1790-2

Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1790-2

Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1790-2

The PHQ-9: validity of a brief depression severity measure

21 January 2018

1 reference

12 December 2020

An update on therapeutics for tobacco dependence

1 reference

12 December 2020

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

1 reference

12 December 2020

Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire

1 reference

12 December 2020

Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin

1 reference

12 December 2020

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

1 reference

12 December 2020

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

1 reference

12 December 2020

Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity

1 reference

12 December 2020

Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.

1 reference

12 December 2020

Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies

1 reference

12 December 2020

Update on pharmacologic options for smoking cessation treatment

1 reference

12 December 2020

A critical review of the cannabinoid receptor as a drug target for obesity management

1 reference

12 December 2020

Cannabinoids and the Digestive Tract

1 reference

12 December 2020

The future of endocannabinoid-oriented clinical research after CB1 antagonists.

1 reference

12 December 2020

Smoking cessation and weight gain

1 reference

12 December 2020

Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving

1 reference

12 December 2020

Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.

1 reference

12 December 2020

Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in

1 reference

12 December 2020

Cigarette smoking: health effects and control strategies

1 reference

12 December 2020

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

1 reference

12 December 2020

Shape of the relapse curve and long-term abstinence among untreated smokers

1 reference

12 December 2020

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake

1 reference

12 December 2020

10.1007/S00213-010-1790-2

Identifiers

DOI

1 reference

Dimensions Publication ID

14 November 2017

1013679092

0 references

1 reference